Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · see citing works

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · see citing works

Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity

Bohannon, R. W., & Smith, M. B. (1987) · Physical Therapy · doi:10.1093/ptj/67.2.206 · Cited by 5,461 · see citing works

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · see citing works

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · see citing works

A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · see citing works

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function

Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307 · see citing works

Amyotrophic lateral sclerosis

Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603 · see citing works

Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623 · see citing works

Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase

Deng, H., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,479 · see citing works

Microglia-specific localisation of a novel calcium binding protein, Iba1

Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · see citing works

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471 · see citing works

Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220 · see citing works

Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy

Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937 · see citing works

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome

Kleyweg, R. P., van der Meché, F. G. A., & Schmitz, P. I. M. (1991) · Muscle & Nerve · doi:10.1002/mus.880141111 · Cited by 935 · see citing works

A Novel Geneiba1in the Major Histocompatibility Complex Class III Region Encoding an EF Hand Protein Expressed in a Monocytic Lineage

Imai, Y., Ibata, I., Ito, D., Ohsawa, K., & Kohsaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1112 · Cited by 872 · see citing works

Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

Howland, D., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B. B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 841 · see citing works

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737 · see citing works

Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

Beers, D. R., Henkel, J. S., Xiao, Q., Zhao, W., Wang, J., Yen, A. A., Siklos, L., McKercher, S. R., & Appel, S. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607423103 · Cited by 733 · see citing works

Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins

Holness, C. L. L., & Simmons, D. (1993) · Blood · doi:10.1182/blood.v81.6.1607.1607 · Cited by 716 · see citing works

Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue

Schnell, S. A., Staines, W. A., & Wessendorf, M. W. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700601 · Cited by 691 · see citing works

A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study

Gijselinck, I., Langenhove, T. V., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., Janssens, J., Bettens, K., Cauwenberghe, C. V., Pereson, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70261-7 · Cited by 635 · see citing works

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

Neumann, M., Kwong, L. K., Lee, E. B., Kremmer, E., Flatley, A., Xu, Y., Forman, M. S., Troost, D., Kretzschmar, H. A., Trojanowski, J. Q., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0477-9 · Cited by 604 · see citing works

Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

Henkel-Tigges, J., Engelhardt, J., Siklós, L., Simpson, E. P., Kim, S. H., Pan, T., Goodman, J. C., Siddique, T., Beers, D. R., & Appel, S. H. (2003) · Annals of Neurology · doi:10.1002/ana.10805 · Cited by 554 · see citing works

Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.

Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed Central · Cited by 546 · see citing works

p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

Al-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., Rogelj, B., Al-Chalabi, A., Hortobágyi, T., & Shaw, C. E. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0911-2 · Cited by 475 · see citing works

Inflammatory processes in amyotrophic lateral sclerosis

McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470 · see citing works

Global Validation of Linear Model Assumptions

Peña, E. A., & Slate, E. H. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000000637 · Cited by 448 · see citing works

Immune reactivity in a mouse model of familial ALS correlates with disease progression

Alexianu, M. E., Kozovska, M., & Appel, S. H. (2001) · Neurology · doi:10.1212/wnl.57.7.1282 · Cited by 438 · see citing works

Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia

Ohsawa, K., Imai, Y., Kanazawa, H., Sasaki, Y., & Kohsaka, S. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.17.3073 · Cited by 420 · see citing works

Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis

Križ, J., Nguyen, M. D., & Julien, J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0487 · Cited by 411 · see citing works

Diffusion tensor MRI assesses corticospinal tract damage in ALS

Ellis, C. M., Simmons, A., Jones, D. K., Bland, J. D. P., Dawson, J. M., Horsfield, M. A., Williams, S., & Leigh, P. N. (1999) · Neurology · doi:10.1212/wnl.53.5.1051 · Cited by 394 · see citing works

Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies

Uryu, K., Nakashima-Yasuda, H., Forman, M. S., Kwong, L. K., Clark, C. M., Grossman, M., Miller, B. L., Kretzschmar, H. A., Lee, V. M.-Y., Trojanowski, J. Q., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31817713b5 · Cited by 382 · see citing works

Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1

Imai, Y., & Kohsaka, S. (2002) · Glia · doi:10.1002/glia.10149 · Cited by 359 · see citing works

Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies

Igaz, L. M., Kwong, L. K., Chen‐Plotkin, A. S., Winton, M. J., Unger, T. L., Xu, Y., Neumann, M., Trojanowski, J. Q., & Lee, V. M. ‐. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809462200 · Cited by 357 · see citing works

Microglia in ALS: The Good, The Bad, and The Resting

Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353 · see citing works

Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS

Drachman, D. B., Frank, K., Dykes‐Hoberg, M., Teismann, P., Almer, G., Przedborski, S., & Rothstein, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10374 · Cited by 307 · see citing works

Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS

Ince, P. G., Evans, J., Knopp, M. V., Forster, G., Hamdalla, H. H. M., Wharton, S. B., & Shaw, P. J. (2003) · Neurology · doi:10.1212/01.wnl.0000058901.75728.4e · Cited by 303 · see citing works

Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72

Murray, M. E., DeJesus‐Hernandez, M., Rutherford, N. J., Baker, M. C., Duara, R., Graff‐Radford, N. R., Wszołek, Z. K., Ferman, T. J., Josephs, K. A., Boylan, K., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0907-y · Cited by 295 · see citing works

Clinical and Pathological Continuum of Multisystem TDP-43 Proteinopathies

Geser, F., Martinez-Lage, M., Robinson, J., Uryu, K., Neumann, M., Brandmeir, N. J., Xie, S. X., Kwong, L. K., Elman, L., McCluskey, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.558 · Cited by 267 · see citing works

Axonal damage markers in cerebrospinal fluid are increased in ALS

Brettschneider, J., Petzold, A., Süßmuth, S. D., Ludolph, A. C., & Tumani, H. (2006) · Neurology · doi:10.1212/01.wnl.0000203120.85850.54 · Cited by 261 · see citing works

Actin-binding Proteins Coronin-1a and IBA-1 are Effective Microglial Markers for Immunohistochemistry

Ahmed, Z., Shaw, G., Sharma, V. P., Yang, C., McGowan, E., & Dickson, D. W. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7156.2007 · Cited by 258 · see citing works

Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease

Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256 · see citing works

Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis

Pehar, M., Cassina, P., Vargas, M. R., Castellanos, R., Viera, L., Beckman, J. S., Estévez, Á. G., & Barbeito, L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02357.x · Cited by 228 · see citing works

Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity

Damme, P. V., Bogaert, E., Dewil, M., Hersmus, N., Kiraly, D., Scheveneels, W., Bockx, I., Braeken, D., Verpoorten, N., Verhoeven, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705046104 · Cited by 216 · see citing works

Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies

Geser, F., Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01091.x · Cited by 195 · see citing works

Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil

Lloyd, C., Richardson, M. P., Brooks, D. J., Al‐Chalabi, A., & Leigh, P. N. (2000) · Brain · doi:10.1093/brain/123.11.2289 · Cited by 178 · see citing works

Mutant SOD1^G93A microglia are more neurotoxic relative to wild‐type microglia

Xiao, Q., Zhao, W., Beers, D. R., Yen, A. A., Xie, W., Henkel, J. S., & Appel, S. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04677.x · Cited by 174 · see citing works

Protective effects of an anti‐inflammatory cytokine, interleukin‐4, on motoneuron toxicity induced by activated microglia

Zhao, W., Xie, W., Xiao, Q., Beers, D. R., & Appel, S. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04172.x · Cited by 172 · see citing works

NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord.

Zhu, X., Hill, R., & Nishiyama, A. (2008) · Neuron Glia Biology · doi:10.1017/s1740925x09000015 · Cited by 168 · see citing works

Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p

Stewart, H. G., Rutherford, N. J., Briemberg, H., Krieger, C., Cashman, N. R., Fabros, M., Baker, M. C., Fok, A., DeJesus‐Hernandez, M., Eisen, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0937-5 · Cited by 156 · see citing works

Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology

Ince, P. G., Highley, J. R., Kirby, J., Wharton, S. B., Takahashi, H., Strong, M. J., & Shaw, P. J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0913-0 · Cited by 154 · see citing works

Increased cytotoxic potential of microglia from ALS‐transgenic mice

Weydt, P., Yuen, E., Ransom, B. R., & Möller, T. (2004) · Glia · doi:10.1002/glia.20062 · Cited by 147 · see citing works

Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis

Brettschneider, J., Libon, D. J., Toledo, J. B., Xie, S. X., McCluskey, L. F., Elman, L. B., Geser, F., Lee, V. M. ‐., Grossman, M., & Trojanowski, J. Q. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0932-x · Cited by 140 · see citing works

An MND/ALS phenotype associated with <i>C9orf72</i> repeat expansion: Abundant p62‐positive, TDP‐43‐negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline

Troakes, C., Maekawa, S., Wijesekera, L., Rogelj, B., Siklós, L., Bell, C., Smith, B., Newhouse, S., Vance, C., Johnson, L., et al. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2011.01286.x · Cited by 124 · see citing works

Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells

Sobue, G., Hashizume, Y., Yasuda, T., Mukai, E., Kumagai, T., Mitsuma, T., & Trojanowski, J. Q. (1990) · Acta Neuropathologica · doi:10.1007/bf00308716 · Cited by 121 · see citing works

Visualization of mitotic radial glial lineage cells in the developing rat brain by Cdc2 kinase-phosphorylated vimentin

Kamei, Y., Inagaki, N., Nishizawa, M., Tsutsumi, O., Taketani, Y., & Inagaki, M. (1998) · Glia · doi:10.1002/(sici)1098-1136(199807)23:3 · Cited by 114 · see citing works

The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis

Wang, L., Sharma, K., Grisotti, G., & Roos, R. P. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.002 · Cited by 114 · see citing works

Glial Cells in Amyotrophic Lateral Sclerosis

Lasiene, J., & Yamanaka, K. (2011) · Neurology Research International · doi:10.1155/2011/718987 · Cited by 110 · see citing works

Pathological 43-kDa Transactivation Response DNA-Binding Protein in Older Adults With and Without Severe Mental Illness

Geser, F., Robinson, J. L., Malunda, J. A., Xie, S. X., Clark, C. M., Kwong, L. K., Moberg, P. J., Moore, E. M., Deerlin, V. M. V., Lee, V. M. ‐., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.254 · Cited by 106 · see citing works

Structure of LEP100, a glycoprotein that shuttles between lysosomes and the plasma membrane, deduced from the nucleotide sequence of the encoding cDNA.

Fambrough, D. M., Takeyasu, K., Lippincott‐Schwartz, J., & Siegel, N. R. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.1.61 · Cited by 104 · see citing works

Quantitative neurohistological features of frontotemporal degeneration

Arnold, S. E., Han, L.-Y., Clark, C. M., Grossman, M., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00173-1 · Cited by 82 · see citing works

Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis

McGeer, E. G., & McGeer, P. L. (2005) · BioDrugs · doi:10.2165/00063030-200519010-00004 · Cited by 75 · see citing works

Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy

Itoh, T., Sobue, G., Ken, E., Mitsuma, T., Takahashi, A., & Trojanowski, J. Q. (1992) · Acta Neuropathologica · doi:10.1007/bf00296785 · Cited by 61 · see citing works

Immunohistochemical application of monoclonal antibodies against myelin basic protein and neurofilament triple protein subunits: advantages over antisera and technical limitations.

Hickey, W. F., Lee, V., Trojanowski, J. Q., McMillan, L. J., McKearn, T. J., Gonatas, J. O., & Gonatas, N. K. (1983) · Journal of Histochemistry & Cytochemistry · doi:10.1177/31.9.6193166 · Cited by 58 · see citing works

Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders

Mosley, R. L., & Gendelman, H. E. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.018 · Cited by 29 · see citing works

Measuring pseudobulbar affect in ALS

Smith, R. A., Berg, J. E., Pope, L. E., & Thisted, R. A. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/17434470410020058 · Cited by 26 · see citing works

C9ORF72, the new gene on the block, causes C9FTD/ALS: new insights provided by neuropathology

Bigio, E. H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0919-7 · Cited by 13 · see citing works

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works

Innate immune activation in neurodegenerative disease

Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · see citing works

Inflammation and white matter degeneration persist for years after a single traumatic brain injury

Johnson, V. E., Stewart, J. E., Begbie, F. D., Trojanowski, J. Q., Smith, D. H., & Stewart, W. (2013) · Brain · doi:10.1093/brain/aws322 · Cited by 1,045 · see citing works

Microglia-mediated neuroinflammation in neurodegenerative diseases

Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 875 · see citing works

Chronic neuropathologies of single and repetitive TBI: substrates of dementia?

Smith, D. H., Johnson, V. E., & Stewart, W. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.29 · Cited by 699 · see citing works

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies

Beers, D. R., & Appel, S. H. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30394-6 · Cited by 387 · see citing works

Inflammation in ALS/FTD pathogenesis

McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 316 · see citing works

Neuroinflammation in frontotemporal dementia

Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280 · see citing works

TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord

Brettschneider, J., Arai, K., Tredici, K. D., Toledo, J. B., Robinson, J. L., Lee, E. B., Kuwabara, S., Shibuya, K., Irwin, D. J., Fang, L., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1299-6 · Cited by 271 · see citing works

<i>TREM2</i>Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis

Cady, J., Koval, E. D., Benitez, B. A., Zaidman, C., Jockel-Balsarotti, J., Allred, P., Baloh, R. H., Ravits, J., Simpson, E., Appel, S. H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6237 · Cited by 262 · see citing works

TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss

Paolicelli, R. C., Jawaid, A., Henstridge, C. M., Valeri, A., Merlini, M., Robinson, J. L., Lee, E. B., Rose, J., Appel, S., Lee, V. M.-Y., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.037 · Cited by 239 · see citing works

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

Toledo, J. B., Van Deerlin, V. M., Lee, E. B., Suh, E., Baek, Y., Robinson, J. L., Xie, S. X., McBride, J., Wood, E. M., Schuck, T., et al. (2014) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2013.06.003 · Cited by 234 · see citing works

Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28

Zürcher, N. R., Loggia, M. L., Lawson, R., Chonde, D. B., Izquierdo-Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., Cudkowicz, M. E., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.009 · Cited by 226 · see citing works

Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function

Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216 · see citing works

How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia

van Blitterswijk, M., DeJesus‐Hernandez, M., & Rademakers, R. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3efb · Cited by 200 · see citing works

Microglia centered pathogenesis in ALS: insights in cell interconnectivity

Brites, D. M. T. O., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 201 · see citing works

Autophagy and ALS: mechanistic insights and therapeutic implications

Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189 · see citing works

Chronic Traumatic Encephalopathy: The Neuropathological Legacy of Traumatic Brain Injury

Hay, J. R., Johnson, V. E., Smith, D. H., & Stewart, W. B., Jr. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044116 · Cited by 193 · see citing works

Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain

Taylor, A. M. W., Castonguay, A., Taylor, A. J., Murphy, N. P., Ghogha, A., Cook, C. P., Xue, L., Olmstead, M. C., Koninck, Y. D., Evans, C. J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4036-14.2015 · Cited by 190 · see citing works

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases

Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182 · see citing works

Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia

Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175 · see citing works

Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum

Cruts, M., Gijselinck, I., Langenhove, T. V., van der Zee, J., & Broeckhoven, C. V. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.010 · Cited by 162 · see citing works

The microglial component of amyotrophic lateral sclerosis

Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164 · see citing works

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

Umoh, M. E., Dammer, E. B., Dai, J., Duong, D. M., Lah, J. J., Levey, A. I., Gearing, M., Glass, J. D., & Seyfried, N. T. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708202 · Cited by 154 · see citing works

Peripheral monocytes are functionally altered and invade the CNS in ALS patients

Zondler, L., Müller, K., Khalaji, S., Bliederhäuser, C., Ruf, W. P., Grozdanov, V., Thiemann, M., Fundel-Clemes, K., Freischmidt, A., Holzmann, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1548-y · Cited by 154 · see citing works

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147 · see citing works

C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation

Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.020 · Cited by 147 · see citing works

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase

Oeckl, P., Weydt, P., Steinacker, P., Anderl-Straub, S., Nordin, F., Volk, A. E., Diehl-Schmid, J., Andersen, P. M., Kornhuber, J., Danek, A., et al. (2019) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2018-318868 · Cited by 139 · see citing works

Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes

Humphrey, J., Venkatesh, S., Hasan, R., Herb, J. T., de Paiva Lopes, K., Küçükali, F., Byrska-Bishop, M., Evani, U. S., Narzisi, G., Fagegaltier, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01205-3 · Cited by 138 · see citing works

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis

Thompson, A. G., Gray, E., Thézénas, M., Charles, P. D., Evetts, S., Hu, M. T., Talbot, K., Fischer, R., Kessler, B. M., & Turner, M. R. (2018) · Annals of Neurology · doi:10.1002/ana.25143 · Cited by 130 · see citing works

Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss

Schludi, M. H., Becker, L., Garrett, L., Gendron, T. F., Zhou, Q., Schreiber, F., Popper, B., Dimou, L., Strom, T. M., Winkelmann, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1711-0 · Cited by 131 · see citing works

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

Jin, M., Günther, R., Akgün, K., Hermann, A., & Ziemssen, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-62756-8 · Cited by 128 · see citing works

Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses

Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125 · see citing works

Disease-modifying therapies in amyotrophic lateral sclerosis

Chiò, A., Mazzini, L., & Mora, G. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107986 · Cited by 114 · see citing works

Neuroimmune regulation of GABAergic neurons within the ventral tegmental area during withdrawal from chronic morphine

Taylor, A. M. W., Castonguay, A., Ghogha, A., Vayssiere, P., Pradhan, A. A. A., Xue, L., Mehrabani, S., Wu, J., Levitt, P., Olmstead, M. C., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.221 · Cited by 109 · see citing works

CSF chitinase proteins in amyotrophic lateral sclerosis

Thompson, A. G., Gray, E., Bampton, A., Raciborska, D., Talbot, K., & Turner, M. R. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320442 · Cited by 106 · see citing works

ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression

Quek, H., Cuní‐López, C., Stewart, R., Colletti, T., Notaro, A., Sun, Y., Guo, C. C., Lupton, M. K., Nguyen, T. H., Oikari, L. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02421-1 · Cited by 105 · see citing works

Exposure of neonatal rats to alcohol has differential effects on neuroinflammation and neuronal survival in the cerebellum and hippocampus

Topper, L. A., Baculis, B. C., & Valenzuela, C. F. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0382-9 · Cited by 101 · see citing works

Traumatic Brain Injury as a Trigger of Neurodegeneration

Johnson, V. E., Stewart, W. B., Jr., Arena, J. D., & Smith, D. H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_15 · Cited by 97 · see citing works

Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers

Puentes, F., Malaspina, A., van Noort, J. M., & Amor, S. (2016) · Brain Pathology · doi:10.1111/bpa.12352 · Cited by 98 · see citing works

Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis

Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Reynolds, B., Pijanowski, O., Chonde, D. B., Izquierdo‐Garcia, D., Mainero, C., Catana, C., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25251 · Cited by 97 · see citing works

Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

Mähler, A., Mandel, S. A., Lorenz, M., Rüegg, U. T., Wanker, E. E., Boschmann, M., & Paul, F. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-5 · Cited by 96 · see citing works

Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective

Malaspina, A., Puentes, F., & Amor, S. (2014) · International Immunology · doi:10.1093/intimm/dxu099 · Cited by 90 · see citing works

Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis

Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Chonde, D. B., Izquierdo‐Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003427 · Cited by 90 · see citing works

White matter microglia heterogeneity in the CNS

Amor, S., McNamara, N. B., Gerrits, E., Marzin, M. C., Kooistra, S. M., Miron, V. E., & Nutma, E. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02389-x · Cited by 89 · see citing works

Senescent Microglia: The Key to the Ageing Brain?

Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84 · see citing works

Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS

Trias, E., Beilby, P. R., Kovacs, M., Ibarburu, S., Varela, V., Barreto-Núñez, R., Bradford, S. C., Beckman, J. S., & Barbeito, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00042 · Cited by 85 · see citing works

The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future

Wobst, H. J., Mack, K. L., Brown, D. G., Brandon, N. J., & Shorter, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21661 · Cited by 83 · see citing works

Plasma Inflammatory Cytokines Are Elevated in ALS

Tortelli, R., Zecca, C., Piccininni, M., Benmahamed, S., Dell’Abate, M. T., Barulli, M. R., Capozzo, R., Battista, P., & Logroscino, G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.552295 · Cited by 84 · see citing works

Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD

Diaper, D. C., Adachi, Y., Lazarou, L., Greenstein, M., Simoes, F. A., di Domenico, A., Solomon, D. A., Lowe, S. A., AlSubaie, R., Cheng, D., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt243 · Cited by 81 · see citing works

Examining the Relationship between Head Trauma and Neurodegenerative Disease: A Review of Epidemiology, Pathology and Neuroimaging Techniques

Sundman, M. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000137 · Cited by 79 · see citing works

NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model

Gugliandolo, A., Giacoppo, S., Bramanti, P., & Mazzon, E. (2017) · Inflammation · doi:10.1007/s10753-017-0667-5 · Cited by 79 · see citing works

C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9

Vahsen, B. F., Nalluru, S., Morgan, G. R., Farrimond, L. E., Carroll, E., Xu, Y., Cramb, K. M. L., Amein, B., Scaber, J., Katsikoudi, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41603-0 · Cited by 78 · see citing works

Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood

Mantovani, S., Gordon, R., Macmaw, J. K., Pfluger, C. M., Henderson, R. D., Noakes, P. G., McCombe, P., & Woodruff, T. M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.005 · Cited by 78 · see citing works

Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD

Chen, H., Kankel, M. W., Su, S. C., Han, S., & Ofengeim, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0060-4 · Cited by 74 · see citing works

CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

López-López, A., Gámez, J., Syriani, E., Morales, M., Salvadó, M., Rodríguez, M. J., Mahy, N., & Vidal-Taboada, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096528 · Cited by 74 · see citing works

RandomForest4Life: A Random Forest for predicting ALS disease progression

Hothorn, T., & Jung, H. H. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.893361 · Cited by 73 · see citing works

The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD

Masrori, P., Beckers, J., Gossye, H., & Damme, P. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00525-z · Cited by 72 · see citing works

What Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis?

Turner, M. R., & Verstraete, E. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0569-6 · Cited by 71 · see citing works

Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion

Leko, M. B., Župunski, V., Kirincich, J., Smilović, D., Hortobágyi, T., Hof, P. R., & Šimić, G. (2019) · Behavioural Neurology · doi:10.1155/2019/2909168 · Cited by 70 · see citing works

Pathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI study

Cárdenas, A. M., Sarlls, J. E., Kwan, J. Y., Bageac, D. V., Gala, Z. S., Danielian, L. E., Ray‐Chaudhury, A., Wang, H., Miller, K. L., Foxley, S., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.04.024 · Cited by 65 · see citing works

Sex Differences in Neurodegeneration: The Role of the Immune System in Humans

Lopez-Lee, C., Kodama, L., & Gan, L. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.002 · Cited by 66 · see citing works

Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology

Pallebage‐Gamarallage, M. M., Foxley, S., Menke, R., Huszár, I. N., Jenkinson, M., Tendler, B. C., Wang, C., Jbabdi, S., Turner, M. R., Miller, K. L., et al. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0416-1 · Cited by 63 · see citing works

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence

Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2022) · Molecules · doi:10.3390/molecules27238448 · Cited by 61 · see citing works

From nucleation to widespread propagation: A prion-like concept for ALS

Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 61 · see citing works

Immune mechanisms and shared immune targets in neurodegenerative diseases

Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 63 · see citing works

MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology

Jara, J. H., Gautam, M., Koçak, N., Xie, E. F., Mao, Q., Bigio, E. H., & Özdi̇nler, P. H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1589-y · Cited by 61 · see citing works

Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis

Buhour, M.-S., Doidy, F., Mondou, A., Pèlerin, A., Carluer, L., Eustache, F., Viader, F., & Desgranges, B. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0267-2 · Cited by 59 · see citing works

Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis

Ratai, E., Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cebulla, C. L., Cernasov, P., Reynolds, B., Fish, J., Seth, R., Babu, S., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.08.007 · Cited by 59 · see citing works

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis

Olesen, M. N., Wuolikainen, A., Nilsson, A. C., Wirenfeldt, M., Forsberg, K., Madsen, J. S., Lillevang, S. T., Brandslund, I., Andersen, P. M., & Asgari, N. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000697 · Cited by 58 · see citing works

Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis

Atassi, N., Xu, M., Triantafyllou, C., Keil, B. R., Lawson, R. J., Cernasov, P., Ratti, E., Long, C. J., Paganoni, S., Murphy, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177680 · Cited by 57 · see citing works

Impaired activation of ALS monocytes by exosomes

Zondler, L., Feiler, M. S., Freischmidt, A., Ruf, W. P., Ludolph, A. C., Danzer, K. M., & Weishaupt, J. H. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.89 · Cited by 56 · see citing works

¹¹ C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis

Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56 · see citing works

Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72 -ALS iPSC-derived microglia contributes to neurodegeneration

Banerjee, P., Mehta, A. R., Nirujogi, R. S., Cooper, J. D., James, O. G., Nanda, J., Longden, J., Burr, K., McDade, K., Salzinger, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq0651 · Cited by 54 · see citing works

Glia-specific autophagy dysfunction in ALS

Strohm, L., & Behrends, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.024 · Cited by 53 · see citing works

Evidence for an early innate immune response in the motor cortex of ALS

Jara, J. H., Genç, B., Stanford, M. J., Pytel, P., Roos, R. P., Weıntraub, S., Mesulam, M. M., Bigio, E. H., Miller, R. J., & Özdi̇nler, P. H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0896-4 · Cited by 52 · see citing works

Microglia in Neurodegenerative Disorders

Tejera, D., & Heneka, M. T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9658-2_5 · Cited by 52 · see citing works

Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K ⁺ currents in neurons

Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., et al. (2020) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x19857818 · Cited by 51 · see citing works

The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis

Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Microbiome · doi:10.1186/s40168-022-01232-z · Cited by 53 · see citing works

Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations

Marian, O. C., Teo, J. D., Lee, J. Y., Song, H., Kwok, J. B., Landin-Romero, R., Halliday, G., & Don, A. S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01544-7 · Cited by 50 · see citing works

Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain

Swanson, M. E. V., Mrkela, M., Murray, H. C., Cao, M. C., Turner, C. P., Curtis, M. A., Faull, R. L. M., Walker, A. K., & Scotter, E. L. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01561-6 · Cited by 50 · see citing works

Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential

You, J., Youssef, M., Santos, J. R., Lee, J., & Park, J. (2023) · Biology · doi:10.3390/biology12101307 · Cited by 56 · see citing works

Crosstalk between Oxidative Stress and Inflammation Caused by Noise and Air Pollution—Implications for Neurodegenerative Diseases

Kuntić, M., Hahad, O., Münzel, T. F., & Daiber, A. (2024) · Antioxidants · doi:10.3390/antiox13030266 · Cited by 50 · see citing works

Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT

Gargiulo, S., Anzilotti, S., Coda, A. R. D., Gramanzini, M., Greco, A., Panico, M., Vinciguerra, A., Zannetti, A., Vicidomini, C., Dollé, F., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3311-y · Cited by 48 · see citing works

Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model

Fellner, A., Barhum, Y., Angel, A., Perets, N., Steiner, I., Offen, D., & Lev, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081666 · Cited by 48 · see citing works

A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis

Marini, C., Cistaro, A., Campi, C., Calvo, A., Caponnetto, C., Nobili, F. M., Fania, P., Beltrametti, M. C., Moglia, C., Novi, G., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3440-3 · Cited by 47 · see citing works

Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts

Albrecht, D., Normandin, M. D., Shcherbinin, S., Wooten, D., Schwarz, A. J., Zürcher, N. R., Barth, V., Guehl, N. J., Akeju, O., Atassi, N., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178335 · Cited by 47 · see citing works

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS

Rostalski, H., Leskelä, S., Huber, N., Katisko, K., Cajanus, A., Solje, E., Marttinen, M., Natunen, T., Remes, A. M., Hiltunen, M. O., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00486 · Cited by 45 · see citing works

Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis

Kjældgaard, A.-L., Pilely, K., Olsen, K. S., Pedersen, S. W., Lauritsen, A. Ø., Møller, K., & Garred, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.007 · Cited by 45 · see citing works

Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis

Cheong, I., Marjańska, M., Deelchand, D. K., Eberly, L. E., Walk, D., & Öz, G. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2248-2 · Cited by 48 · see citing works

Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS

Hilton, J. B. W., Kysenius, K., Liddell, J. R., Mercer, S. W., Paul, B. T., Beckman, J. S., McLean, C., White, A. R., Donnelly, P. S., Bush, A. I., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-55832-w · Cited by 45 · see citing works

Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).

Volpe, N. J., Simonett, J. M., Fawzi, A. A., & Siddique, T. (2015) · PubMed Central · Cited by 45 · see citing works

The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis

Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 45 · see citing works

Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C 9 ORF 72 hexanucleotide repeat expansion: a systematic neuropathological review

Schipper, L. J., Raaphorst, J., Aronica, E., Baas, F., de Haan, R. J., de Visser, M., & Troost, D. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12284 · Cited by 41 · see citing works

Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis

Chew, S., & Atassi, N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00135 · Cited by 43 · see citing works

The Genetics of C9orf72 ExpansionsPreprint

Gijselinck, I., Cruts, M., & Broeckhoven, C. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026757 · Cited by 40 · see citing works

Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice

Zhang, Y., Xia, Y., & Sun, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2363880 · Cited by 42 · see citing works

Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis

Crisafulli, S. G., Brajkovic, S., Mis, M. S. C., Parente, V., & Corti, S. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0532-4 · Cited by 40 · see citing works

The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis

He, D., Xu, Y. C., Liu, M., & Cui, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0519 · Cited by 42 · see citing works

Understanding the role of microglia in the pathogenesis of amyotrophic lateral sclerosis

Vahsen, B. F. (2022) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-o5xrvbbq0

Microglia in C9orf72–associated amyotrophic lateral sclerosis: More or less active?

Vahsen, B. F., & Pasterkamp, R. J. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01831

Hexanucleotide repeat expansions in C9orf72 alter microglial responses and prevent a coordinated glial reaction in ALSPreprint

Masrori, P., Bijnens, B., Davie, K., Poovathingal, S. K., Storm, A., Hersmus, N., Fumagalli, L., Bosch, L. V. D., Fiers, M. W. E. J., Thal, D. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.26.513909 · Cited by 4 · see citing works

Hexanucleotide repeat expansions in C9orf72 alter microglial responses and prevent a coordinated glial reaction in ALS (P1-6.002)

Masrori, P., Bijnens, B., Davie, K., Poovathingal, S. K., Storm, A., Hersmus, N., Fumagalli, L., Bosch, L. V. D., Fiers, M. W. E. J., Thal, D. R., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000203562 · Cited by 1 · see citing works

C9orf72 hexanucleotide repeat expansions impair microglial response in ALS

Masrori, P., Bijnens, B., Fumagalli, L., Davie, K., Poovathingal, S. K., Meese, T. S., Storm, A., Hersmus, N., Fazal, R., van den Biggelaar, D., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02075-1 · Cited by 30 · see citing works